Dermatology Made Easy is based on the most popular topics from DermNet NZ's vast array of material. The book combines the essential focus of the ‘Made Easy’ book series with the authority and knowledge base of DermNet NZ's unparalleled resources.
Author: Weng Chyn Chan MB ChB, Dept of Dermatology Waikato Hospital, Hamilton, New Zealand, 2004.
Rifampicin is an antibiotic used to treat serious bacterial infections. It may be prescribed by dermatologists for the treatment of:
Rifampicin is active against a variety of organisms including Staphylococcus aureus, Staphylococcus epidermidis, Mycobacterium tuberculosis, Mycobacterium leprae, Neisseria meningiditis and Brucella species.
It should always be prescribed with another antibiotic, in order to prevent bacterial resistance, which can develop rapidly if it is used alone.
It should be taken on an empty stomach at least 30 minutes before a meal or 2 hours after a meal. Antacids should be given at least 1 hour after rifampicin.
In New Zealand rifampicin is available as:
Rifampicin is usually well tolerated and rarely causes serious toxicity. The commonest side effects involve skin and the gastrointestinal system.
|Bodily fluids||Tears, sweat and urine may become orange coloured and contact lenses may be permanently stained. Usually mild and self-limiting.|
|Skin||flushing and itching with or without rash. Hives are uncommon. Erythema multiforme and toxic epidermal necrolysis have rarely been reported.|
|Gastrointestinal||Loss of appetite, vomiting, abdominal pain and diarrhoea.|
|Liver||Hepatitis, particularly if rifampicin is given with isoniazid.|
|Blood||Thrombocytopenia (low platelets potentially resulting in bruising and bleeding); rarely, low white blood cell count and disseminated intravascular coagulation; and very rarely, agranulocytosis (severely decreased white blood cell counts).|
|Musculoskeletal||Muscle weakness and myopathy are uncommon.|
Rifampicin is sometimes used intermittently (less than 2 to 3 doses per week) for the treatment of tuberculosis and leprosy. When rifampicin is used in this way, it may be associated with a ‘flu-like syndrome, shortness of breath, low blood pressure, acute renal failure and shock.
Rifampicin is a P-glycoprotein inducer and may increase the breakdown of other medications, making them less effective. The dosage of these drugs may need adjustment if taken together with rifampicin:
See the DermNet NZ bookstore
© 2018 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.